31 results
10-K/A
2021 FY
RNAC
Cartesian Therapeutics Inc
28 Apr 22
Annual report (amended)
7:45am
Hispanic or Latinx
Native Hawaiian or Pacific Islander
White
Two or More Races or Ethnicities
LGBTQ+
Did Not Disclose Demographic Background
Anti-Hedging … Trading Compliance Policy prohibits our directors, officers and employees and any entities they control from engaging in all hedging or monetization
8-K
EX-10.2
RNAC
Cartesian Therapeutics Inc
13 Nov 23
Entry into a Material Definitive Agreement
9:02am
the writing or settlement of options or other hedging transactions, whether such options are listed on an options exchange or otherwise;
a combination of any … in compliance with FINRA IM-2121.01.
In connection with sales of the Shares or otherwise, the selling stockholders may enter into hedging transactions
DEFR14A
9vo4qo68l7
3 May 22
Revised proxy
2:15pm
PRE 14A
22if0qhxot6
22 Apr 22
Preliminary proxy
3:08pm
8-K/A
EX-99.1
oubckwr55d7bw
23 Jan 24
Independent Auditor’s Report
4:05pm
424B5
v1oi5ii7gwu4 4w
6 Apr 22
Prospectus supplement for primary offering
9:45pm